Key result
Cangrelor achieves complete thrombus disaggregation and vessel recanalization in a murine thrombosis model.
Why the study?
Existing arterial thrombosis models are limited by biphasic thrombus dynamics, which prevents assessing thrombus destabilization, disaggregation, or thrombolysis after pharmacological treatment.
Does post-onset administration of antithrombotic agents disaggregate or destabilize a pre-formed stable thrombus in a murine FeCl3-induced carotid artery thrombosis model?
Population
Murine stable thrombosis model of carotid artery injury
Comparison
Various antithrombotic agents administered 15 min after initiation of thrombosis
Design
Preclinical animal model study
Follow-up
45 min
Authors
Loading...
Extends antithrombotic testing to preformed stable thrombi in mice; leaves open translation to human arterial thrombosis.
Does post-onset administration of antithrombotic agents disaggregate or destabilize a pre-formed stable thrombus in a murine FeCl3-induced carotid artery thrombosis model?
p-value: p=0.002
A novel 2-spot FeCl3-induced murine stable thrombosis model successfully allows for the evaluation of the curative effects of antithrombotic and thrombolytic agents on preformed arterial thrombi.
Fauth et al. (2026) studied Arterial thrombosis. Antithrombotic agents (Cangrelor, GR 144053 trihydrochloride) vs. Saline was evaluated on Thrombus area (Area Under the Curve) (p=0.002). In a novel murine stable thrombosis model, administration of cangrelor or GR 144053 trihydrochloride 15 minutes after injury induced complete thrombus disaggregation and vessel recanalization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: